Senate Candidates Clash on Cannabis in Key 2026 Midterm Races
Competitive Senate contests now hinge on legalization stances as federal reform stalls.

A group of diverse individuals standing confidently in front of an American flag at an election podium.
Federal Legalization Splits Tight Races
Democratic challengers in Ohio, Florida, and Montana are campaigning on full federal descheduling, while Republican incumbents oppose any reclassification beyond Schedule III. The divide mirrors the stalled SAFER Banking Act, which has languished in the House since its April 2026 Senate passage.
In Ohio, Democratic candidate Sarah Patel has pledged to co-sponsor a bill removing cannabis from the Controlled Substances Act entirely. Her opponent, incumbent Republican Senator Mike Harlan, supports the DEA's proposed Schedule III move but opposes state-level adult-use programs.
Banking Reform as Wedge Issue
Access to traditional banking services has become a litmus test, with Democrats backing SAFER Banking and Republicans calling it premature. Montana's Democratic challenger James Whitfield has made cannabis banking the centerpiece of his rural economic pitch. Cash-only dispensaries face robbery risk, he argues.
Republican Senator Lisa Grant counters that federal banking protections should wait until DEA rescheduling is finalized. She's cited concerns about anti-money-laundering compliance gaps.
State Discretion and Enforcement
Florida's Senate race has zeroed in on whether states should retain enforcement autonomy if federal law changes. Democratic candidate Carlos Ruiz supports a federalism model allowing states to ban sales even if Congress legalizes, but Republican Senator Tom Bradley has attacked that stance as inconsistent. Ruiz simultaneously backs preempting state bans on hemp-derived THCA products, Bradley notes.
The THCA angle is live in Florida. State regulators proposed emergency rules in July 2026 to cap total THC in hemp products at 0.3 percent by dry weight, a standard that would eliminate most intoxicating hemp goods.
Voter Priorities Shift in Medical-Only States
Polling shows cannabis policy ranks fourth or fifth among likely voters in states with medical programs but no adult-use access. A July 2026 survey by the Cannabis Voter Project found 62 percent of Ohio voters and 58 percent of Florida voters support federal legalization. Independents break 70 percent in favor.
That's up from 54 percent in Ohio and 51 percent in Florida in comparable 2024 polling.
280E Tax Reform Enters the Debate
Democratic candidates in three races have called for immediate repeal of Internal Revenue Code Section 280E, which bars cannabis businesses from deducting ordinary expenses. The tax provision costs operators an estimated $1.8 billion annually in excess federal tax liability, according to a 2025 analysis by the Marijuana Policy Project.
No Republican candidate has endorsed 280E repeal. Senator Harlan in Ohio has proposed a compromise: allow deductions only for state-licensed medical operators, excluding adult-use businesses.
Industry PAC Spending Tilts Democratic
Cannabis industry political action committees have directed 78 percent of their $4.2 million in disclosed 2026 Senate contributions to Democratic candidates. The largest donor, the National Cannabis Roundtable PAC, has given $620,000 to five Democratic challengers and zero to Republican incumbents, per Federal Election Commission filings through July 31, 2026.
What to Watch Through November
The next inflection point is the September 12, 2026 Senate Banking Committee hearing on SAFER Banking, where three of the contested-race incumbents sit. Democratic challengers have already signaled they'll use any Republican no-votes as attack-ad fodder in the final eight weeks before Election Day.
For deeper context on how cannabis is reshaping Senate dynamics, see the CannIntel topic hub on 2026 Senate Elections and Cannabis Policy. State-level enforcement stances will likely remain unsettled until DEA finalizes its rescheduling rule, currently projected for late September 2026.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

New Jersey Bill Extending Hemp Drink Sales Advances
A bill to extend New Jersey hemp drink sales moved forward Oct. 22, but the public record behind the headline is thin.

Wisconsin Governor Nominees Crowley, Tiffany Back Legalization in Debate
Democrat David Crowley and Republican Tom Tiffany both endorsed some form of marijuana legalization on the debate stage, but split on how far and how fast Wisconsin should go.

DEA Urges Judge to Wrap Up Marijuana Rescheduling Process
The DEA asked the judge overseeing marijuana rescheduling to finish the process and avoid side fights, Cannabis Business Times reported, as the Schedule III proposal nears its third year.
More from the newsroom

Survey of 7,913 German Patients Finds Pharmacy Cannabis Preferred
A survey of 7,913 German medicinal cannabis patients, nearly 90% with experience of both channels, points to the illegal market as a major source of stress.

Virginia Sen. L. Louise Lucas indicted in marijuana business case
The Washington Post reported the indictment of Virginia's Senate president pro tempore, a figure in state cannabis debates. The charging details were not in the initial report.

Vireo Growth acquires Palatka cannabis facility for $21M
The multistate operator paid $21 million for a Palatka site, a hard-asset bet on Florida's medical market while Canada and Germany show the cost of overbuilding.